Imperial College London Featured PhD Programmes
Xi’an Jiaotong-Liverpool University Featured PhD Programmes
Heriot-Watt University Featured PhD Programmes
University of Portsmouth Featured PhD Programmes
University of Reading Featured PhD Programmes

Cancer / Oncology (natural) PhD Projects, Programs & Scholarships

We have 25 Cancer / Oncology (natural) PhD Projects, Programs & Scholarships

  • "natural" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 11 to 20 of 25
  Molecular cancer therapeutics activated by radioisotope-generated Cerenkov radiation
  Dr J Knight, Dr R Pal, Dr K Rankin
Application Deadline: 6 March 2020

Funding Type

PhD Type

The beta-particles emitted by certain medical radioisotopes can travel faster than light through the human body. When this happens, a photonic boom - comparable to a sonic boom – releases energy in the form of Cerenkov radiation which has a characteristic blue glow.
  Transglutaminase 2 (TG2) as a novel cancer biomarker and target for chemotherapy
  Research Group: Biomedical Research Group
  Dr P Coussons, Dr C Pike
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  PhD Cancer Genetics - Examining how telomere dysfunction drives the evolution of the cancer genome
  Prof D Baird, Dr K Cleal
Application Deadline: 1 March 2020

Funding Type

PhD Type

Telomeres are structures that cap the ends of eukaryotic chromosomes, preventing the recognition and repair of the natural chromosomal terminus by the DNA damage response (DDR) apparatus.
  Developing New Tools for the Chemical Diversification of Peptide Scaffolds
  Dr SL Cobb, Prof A Kawamura, Prof M Waring
Application Deadline: 6 March 2020

Funding Type

PhD Type

Peptides are useful leads for the development of new drugs against a wide range of diseases. They occupy the chemical space between small molecules and antibodies and as such they can reach or selectively inhibit drug targets that these other molecules cannot.
  FGFR signalling in breast cancer
  Dr A Chioni
Applications accepted all year round

Funding Type

PhD Type

Growth factors are used during development to convey messages that tell cells to divide, survive, migrate and adopt a particular fate.
  PhD program in Molecular Inflammation, Molecular Medicine and Advanced Medical Biomarker Research

Funding Type

PhD Type

Projects starting October 1, 2020. Application deadline. March 30, 2020.
  Reversing multidrug chemoresistance in head and neck cancer
  Dr M T Teh
Applications accepted all year round

Funding Type

PhD Type

Background. Multidrug resistance renders chemotherapeutic treatment failure in large proportion of head and neck squamous cell carcinoma (HNSCC) patients requiring multimodal therapy involving chemotherapy in conjunction with surgery and/or radiotherapy.
  Defining the immune cells which best fight cancer
  Prof D Davis
Application Deadline: 4 March 2020

Funding Type

PhD Type

Arguably, immune therapies for cancer are at a tipping point. The success of therapies for some patients with some types of cancer has made it clear that immunotherapies can work.
  Investigating the role of DNA structures genetic diseases such as cancer and diabetes (WALLERZU20SF)
  Dr Z Waller, Dr C Morris
Application Deadline: 31 May 2020

Funding Type

PhD Type

It is often assumed that DNA exists only as the iconic Watson-Crick double helix but it can actually adopt many different types of structure depending on the sequence and environmental conditions.
  Metabolic reprogramming in cancer: starving tumors of essential nutrients to promote cell death
  Dr S Papa
Applications accepted all year round

Funding Type

PhD Type

All the cells in our bodies are programmed to die. As they get older, our cells accumulate toxic molecules that make them sick. In response, they eventually break down and die, clearing the way for new, healthy cells to grow.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.